A Study to Examine the Effect of Pramlintide on Body Weight and Its Safety and Tolerability in Obese Subjects

A Study to Evaluate the Effect on Body Weight of Leptin Administered in Conjunction With Pramlintide in Overweight and Obese Subjects

NCT00392925 ·Status: COMPLETED ·Phase: PHASE2

A Study To Examine The Efficacy And Safety Of Pramlintide+Metreleptin In Obese Subjects

NCT01235741 ·Status: TERMINATED ·Phase: PHASE2

Evaluation of the Effect of Pramlintide on Satiety and Food Intake

NCT00042601 ·Status: COMPLETED ·Phase: PHASE2

Safety, Pharmacokinetics and Pharmacodynamics Study to Evaluate BMS-830216 in Obese Subjects

NCT00909766 ·Status: COMPLETED ·Phase: PHASE1/PHASE2

Phase 2 Study to Evaluate Safety and Efficacy of RM-493 in Obese Participants

NCT01749137 ·Status: COMPLETED ·Phase: PHASE2

Safety Study to Evaluate BMS-830216 in Healthy Subjects

NCT00878020 ·Status: COMPLETED ·Phase: PHASE1

A Study to Evaluate the Efficacy and Safety of PF-06882961 in Adults With Obesity

NCT04707313 ·Status: COMPLETED ·Phase: PHASE2

Investigating Safety, Tolerability, PK and PD for Multiple Doses of NNC9204-0530 in Combination With Liraglutide in Male and Female Subjects Being Overweight or With Obesity

NCT02870231 ·Status: COMPLETED ·Phase: PHASE1

A Long-Term Study To Examine The Effects Of CP-945,598 On Weight Loss And Safety

NCT00375401 ·Status: TERMINATED ·Phase: PHASE3

Safety and Efficacy Study of S-309309 in Obese Adults

NCT05925114 ·Status: COMPLETED ·Phase: PHASE2

Multiple Ascending Dose Study of AMG 598 in Adults With Obesity

NCT03757130 ·Status: COMPLETED ·Phase: PHASE1

This is a Multi-centre, Multi-drug, Platform Study in Chinese Participants Living With Obesity / Overweight

NCT07017179 ·Status: RECRUITING ·Phase: PHASE2

The Efficacy and Safety of Liraglutide on Body Weight Loss in Obese and Overweight Patients

NCT04605861 ·Status: COMPLETED ·Phase: PHASE3

A Study in Participants With Obesity or Overweight With at Least One Weight-related Comorbidity

NCT06595238 ·Status: COMPLETED ·Phase: PHASE2

A 2-Year Study of an Investigational Drug in Obese Patients (0557-011)

NCT00092859 ·Status: COMPLETED ·Phase: PHASE3

A Multiple Dose Study to Assess the Safety and Tolerability of BMS-963272 in Obese But Otherwise Healthy Adults

NCT04116632 ·Status: COMPLETED ·Phase: PHASE1

Effects of AZD5004 in Adults Who Are Living With Obesity or Overweight With at Least 1 Weight-related Comorbidity

NCT06579092 ·Status: COMPLETED ·Phase: PHASE2

Research Study Investigating Study Medicine (NNC9204-1177) for Weight Management in People With Overweight or Obesity

NCT03308721 ·Status: COMPLETED ·Phase: PHASE1

A Research Study of How NNC0174-0833 Taken With Semaglutide Works in People Who Are Overweight or Obese

NCT03600480 ·Status: COMPLETED ·Phase: PHASE1

Efficacy, Safety and Tolerability of AZD6234 in Participants Living With Overweight or Obesity With Type 2 Diabetes Who Are on a Stable Dose of GLP-1 Receptor Agonist

NCT06851858 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE2

AMAZE 1: A Research Study Investigating How Well the Medicine NNC0487-0111 Helps People With Excess Body Weight Lose Weight

NCT07339423 ·Status: RECRUITING ·Phase: PHASE3

A Study to Investigate the Safety, Tolerability and Pharmacodynamics of AZD4144 in Participants With Obesity

NCT06942923 ·Status: COMPLETED ·Phase: PHASE1

Efficacy and Safety of ATL-962 in Obese Diabetics

NCT00156897 ·Status: COMPLETED ·Phase: PHASE2

Research Study of a New Medicine (NNC9204-1706) in People With Overweight or Obesity

NCT03661879 ·Status: COMPLETED ·Phase: PHASE1

A Study to Assess the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of AZD6234 After Repeat Dose Administration in Participants Who Are Overweight or Obese

NCT06132841 ·Status: COMPLETED ·Phase: PHASE1